| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4.3M | — | +575.4% |
| Cost of Revenue | $11.8M | — | +128.7% |
| Gross Profit | -$7.5M | — | -65.4% |
| R&D Expense | $4.1M | — | +166.1% |
| SG&A Expense | $9.5M | — | +40.7% |
| Operating Income | -$21.1M | — | -64.3% |
| Pre-tax Income | -$19.9M | — | +3.5% |
| Income Tax | -$34K | — | — |
| Net Income | -$19.9M | — | +3.7% |
| EPS (Basic) | -$1.99 | — | +57.5% |
| EPS (Diluted) | -$1.99 | — | +57.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $600K | -95.4% | -77.3% |
| Accounts Receivable | $3.4M | -12.0% | — |
| Inventory | $37.3M | -4.6% | -9.8% |
| Current Assets | $47.0M | -21.4% | -39.3% |
| Total Assets | $102.7M | -12.9% | -11.0% |
| Current Liabilities | $38.3M | -1.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$16.5M | — | -102.5% |
| Capital Expenditures | $125K | — | +599.7% |
| Investing Cash Flow | -$125K | — | -599.7% |
| Financing Cash Flow | $5.0M | — | -85.3% |
| Free Cash Flow | -$16.6M | — | -103.6% |
| -52.4% |
| Long-term Debt | $15.7M | +1.6% | — |
| Total Liabilities | $76.5M | +2.3% | -9.0% |
| Stockholders' Equity | $26.2M | -39.1% | -16.6% |